CalciMedica Files Proxy Materials
Ticker: CALC · Form: DEFA14A · Filed: Apr 30, 2025 · CIK: 1534133
| Field | Detail |
|---|---|
| Company | Calcimedica, INC. (CALC) |
| Form Type | DEFA14A |
| Filed Date | Apr 30, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-filing, corporate-governance
TL;DR
CalciMedica filed proxy docs, no fee. Looks like they're moving forward with shareholder stuff.
AI Summary
CalciMedica, Inc. filed a Definitive Additional Materials proxy statement on April 30, 2025. This filing relates to the company's proxy materials and does not involve a fee. The company, formerly known as Graybug Vision, Inc., is incorporated in Delaware and operates in the pharmaceutical preparations sector.
Why It Matters
This filing indicates that CalciMedica is proceeding with corporate actions requiring shareholder approval, which could impact the company's strategic direction and future operations.
Risk Assessment
Risk Level: low — This is a routine filing of proxy materials and does not contain information about significant financial events or strategic shifts that would inherently increase risk.
Key Players & Entities
- CalciMedica, Inc. (company) — Registrant
- Graybug Vision, Inc. (company) — Former company name
- DEFA14A (document) — Filing type
FAQ
What is the purpose of this DEFA14A filing?
This filing is a Definitive Additional Materials proxy statement filed by CalciMedica, Inc. to provide information required in a proxy statement.
When was this filing made?
The filing was made on April 30, 2025.
Does this filing involve a fee?
No, the filing explicitly states 'No fee' is required.
What is CalciMedica, Inc.'s former name?
CalciMedica, Inc. was formerly known as Graybug Vision, Inc., with name changes occurring in 2017 and 2015.
What is CalciMedica's primary business sector?
CalciMedica, Inc. operates in the Pharmaceutical Preparations sector, with Standard Industrial Classification code 2834.
Filing Details
This Form DEFA14A (Form DEFA14A) was filed with the SEC on April 30, 2025 regarding CalciMedica, Inc. (CALC).